• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORP CLEARLINK SYSTEM NON-DEHP SECONDARY MEDICATION SET WITH DUO-VENT SPIKE (37 INCH; SECONDARY TUBING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORP CLEARLINK SYSTEM NON-DEHP SECONDARY MEDICATION SET WITH DUO-VENT SPIKE (37 INCH; SECONDARY TUBING Back to Search Results
Model Number 2H7462
Device Problem Particulates (1451)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/14/2015
Event Type  Injury  
Event Description
On (b)(6) 2015 a dose of acyclovir 660 mg prepared on 0.9% nacl 100 ml was administered as a secondary infusion using a clearlink system non-dehp secondary medication set with a duo-vent spike (37 inch tubing) manufactured by baxter healthcare corp (item# 2h7462).(the acyclovir concentration was 6.6 mg/ml, which is within the recommended concentration of <7 mg/ml established by the manufacturer.) the acyclovir infusion was piggybacked into a primary line that was infusing d4w/0.45% nacl.The secondary line as flushed with d5w/0.45% nacl prior to use, which is physically and chemically compatible with acyclovir.Prior to initiation of the acyclovir and d5w/0.45% nacl infusions, all infusions and tubing were free of visible particulate matter.Immediately following initiation of the acyclovir infusion, the fluid contained in the drip chamber of the secondary line in question became cloudy in appearance, reflecting rapid development of particulate matter.The acyclovir infusion was terminated before particulate matter reached the pt via secondary tubing.The secondary line had been in use for approx 90 hours at the time the event occurred.The pt's medication list was assessed for potential incompatible intravenous medications, none of which were administered immediately prior to acyclovir or d5w/0.45% nacl, suggesting that medication or fluid incompatibility did not contribute to precipitate formation.The lot number of the secondary line in question was not documented prior to use.However, lot numbers of secondary tubing present in the pt care area at the time the event occurred included: r15a19134, r14l01099, and r14028098.Given the inability to identify add'l factors that may have contributed to precipitate formation, the possibility of a defect within the tubing is being proposed for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK SYSTEM NON-DEHP SECONDARY MEDICATION SET WITH DUO-VENT SPIKE (37 INCH
Type of Device
SECONDARY TUBING
Manufacturer (Section D)
BAXTER HEALTHCARE CORP
deerfield IL
MDR Report Key4728342
MDR Text Key5669293
Report NumberMW5042259
Device Sequence Number1
Product Code FPA
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 04/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2H7462
Device Catalogue Number2H7462
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/20/2015
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age16 YR
Patient Weight73
-
-